COMPANY

에티테마 - ety.kr
introducing 3

Introduction

MEDI-IoT (메디아이오티) is a BT (Bio Technology) convergence company that provides digital prevention/management/treatment solutions in the fields of eye diseases and geriatric diseases. Currently, we offer the eye disease treatment device MEDI-EYE (메디아이) and DTx platform called AgingLOC (에이징락), which diagnoses and provides tailored treatment programs for geriatric diseases. MEDI-IoT provides optimal solutions that meet the needs of customers in the fields of eye diseases and geriatric diseases and has a differentiated approach that sets new standards for treatment. We strive to become a pioneer in the digital healthcare field through continuous research and innovation, and we are committed to improving people's quality of daily life.

Timeline of History

History

December 2025

Signed MOU between Mediiot and NK Medical

October 2025

Registered 1 Domestic Patent (10-2877512), Completed 1 US Application (19/476,995)

September 2025

Completed 1 Chinese Patent Application ('202480015045.8)

May 2025

Secured Investment from ScaleUp Partners

April 2025

Approved for Exploratory Clinical Trial of MEDI-EYE for Dry Eye Syndrome

February 2025

Obtained MEDI-EYE-w China SRRC Certification

January 2025

Obtained ISO 9001 Certification

December 2024

Obtained MEDI-EYE-w US FCC Certification

November 2024

Designated as Innovative Medical Device, Obtained MEDI-EYE-w KC Certification

April 2024

Participated in Hong Kong InnoEx 2024 and Awarded Innovation Prize

March 2024

Obtained MEDI-EYE KC Certification

April 2023

Secured Investment from ScaleUp Partners

January 2023

Participated in CES 2023

September 2022

Selected for TIPS (Startup Incubating Support Program)

August 2022

Secured Investment from Hana Securities, Company X

May 2022

Secured Investment from Daewoong Pharmaceutical

October 2020

Founded Mediiot, Established Affiliated Research Institute